194 related articles for article (PubMed ID: 32660099)
1. Cuban Brown Propolis Interferes in the Crosstalk between Colorectal Cancer Cells and M2 Macrophages.
Frión-Herrera Y; Gabbia D; Scaffidi M; Zagni L; Cuesta-Rubio O; De Martin S; Carrara M
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32660099
[TBL] [Abstract][Full Text] [Related]
2. The Cuban Propolis Component Nemorosone Inhibits Proliferation and Metastatic Properties of Human Colorectal Cancer Cells.
Frión-Herrera Y; Gabbia D; Scaffidi M; Zagni L; Cuesta-Rubio O; De Martin S; Carrara M
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32155848
[TBL] [Abstract][Full Text] [Related]
3. Nemorosone inhibits the proliferation and migration of hepatocellular carcinoma cells.
Frión-Herrera Y; Gabbia D; Cuesta-Rubio O; De Martin S; Carrara M
Life Sci; 2019 Oct; 235():116817. PubMed ID: 31476309
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
[TBL] [Abstract][Full Text] [Related]
5. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
[No Abstract] [Full Text] [Related]
6. Chemosensitizing activity of Cuban propolis and nemorosone in doxorubicin resistant human colon carcinoma cells.
Frión-Herrera Y; Gabbia D; Díaz-García A; Cuesta-Rubio O; Carrara M
Fitoterapia; 2019 Jul; 136():104173. PubMed ID: 31085307
[TBL] [Abstract][Full Text] [Related]
7. M2-like tumor-associated macrophages promote epithelial-mesenchymal transition through the transforming growth factor β/Smad/zinc finger e-box binding homeobox pathway with increased metastatic potential and tumor cell proliferation in lung squamous cell carcinoma.
Sumitomo R; Menju T; Shimazu Y; Toyazaki T; Chiba N; Miyamoto H; Hirayama Y; Nishikawa S; Tanaka S; Yutaka Y; Yamada Y; Nakajima D; Ohsumi A; Hamaji M; Sato A; Yoshizawa A; Huang CL; Haga H; Date H
Cancer Sci; 2023 Dec; 114(12):4521-4534. PubMed ID: 37806311
[TBL] [Abstract][Full Text] [Related]
8. 13-Methyl-palmatrubine shows an anti-tumor role in non-small cell lung cancer via shifting M2 to M1 polarization of tumor macrophages.
Wu Z; Zhou J; Chen F; Yu J; Li H; Li Q; Li W
Int Immunopharmacol; 2022 Mar; 104():108468. PubMed ID: 35066343
[TBL] [Abstract][Full Text] [Related]
9. Zoledronic acid inhibits thyroid cancer stemness and metastasis by repressing M2-like tumor-associated macrophages induced Wnt/β-catenin pathway.
Lv J; Chen FK; Liu C; Liu PJ; Feng ZP; Jia L; Yang ZX; Hou F; Deng ZY
Life Sci; 2020 Sep; 256():117925. PubMed ID: 32522570
[TBL] [Abstract][Full Text] [Related]
10. M2-like macrophages induce colon cancer cell invasion via matrix metalloproteinases.
Vinnakota K; Zhang Y; Selvanesan BC; Topi G; Salim T; Sand-Dejmek J; Jönsson G; Sjölander A
J Cell Physiol; 2017 Dec; 232(12):3468-3480. PubMed ID: 28098359
[TBL] [Abstract][Full Text] [Related]
11. 20(S)-ginsenoside Rh2 as agent for the treatment of LMN-CRC via regulating epithelial-mesenchymal transition.
Yuan Y; Wang J; Xu M; Zhang Y; Wang Z; Liang L; Sun P
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32141497
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
13. Role of tumor-associated macrophages at the invasive front in human colorectal cancer progression.
Inagaki K; Kunisho S; Takigawa H; Yuge R; Oka S; Tanaka S; Shimamoto F; Chayama K; Kitadai Y
Cancer Sci; 2021 Jul; 112(7):2692-2704. PubMed ID: 33964093
[TBL] [Abstract][Full Text] [Related]
14. Low-dose naltrexone inhibits the epithelial-mesenchymal transition of cervical cancer cells in vitro and effects indirectly on tumor-associated macrophages in vivo.
Liu N; Ma M; Qu N; Wang R; Chen H; Hu F; Gao S; Shan F
Int Immunopharmacol; 2020 Sep; 86():106718. PubMed ID: 32585612
[TBL] [Abstract][Full Text] [Related]
15. M2-polarized tumor-associated macrophages promote epithelial-mesenchymal transition via activation of the AKT3/PRAS40 signaling pathway in intrahepatic cholangiocarcinoma.
Sun D; Luo T; Dong P; Zhang N; Chen J; Zhang S; Dong L; Janssen HLA; Zhang S
J Cell Biochem; 2020 Apr; 121(4):2828-2838. PubMed ID: 31692069
[TBL] [Abstract][Full Text] [Related]
16. M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway.
Liu CY; Xu JY; Shi XY; Huang W; Ruan TY; Xie P; Ding JL
Lab Invest; 2013 Jul; 93(7):844-54. PubMed ID: 23752129
[TBL] [Abstract][Full Text] [Related]
17. Dexamethasone inhibits hypoxia-induced epithelial-mesenchymal transition in colon cancer.
Kim JH; Hwang YJ; Han SH; Lee YE; Kim S; Kim YJ; Cho JH; Kwon KA; Kim JH; Kim SH
World J Gastroenterol; 2015 Sep; 21(34):9887-99. PubMed ID: 26379394
[TBL] [Abstract][Full Text] [Related]
18. β-Carotene exerts anti-colon cancer effects by regulating M2 macrophages and activated fibroblasts.
Lee NY; Kim Y; Kim YS; Shin JH; Rubin LP; Kim Y
J Nutr Biochem; 2020 Aug; 82():108402. PubMed ID: 32450500
[TBL] [Abstract][Full Text] [Related]
19. Ceramide and palmitic acid inhibit macrophage-mediated epithelial-mesenchymal transition in colorectal cancer.
de Araujo Junior RF; Eich C; Jorquera C; Schomann T; Baldazzi F; Chan AB; Cruz LJ
Mol Cell Biochem; 2020 May; 468(1-2):153-168. PubMed ID: 32222879
[TBL] [Abstract][Full Text] [Related]
20. Soluble CXCL16 in preoperative serum is a novel prognostic marker and predicts recurrence of liver metastases in colorectal cancer patients.
Matsushita K; Toiyama Y; Tanaka K; Saigusa S; Hiro J; Uchida K; Inoue Y; Kusunoki M
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S518-27. PubMed ID: 21845497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
